Oncotelic Therapeutics, Inc. Notes Issued
Oncotelic Therapeutics, Inc. (OTLC) reported Notes Issued of $71.75 thousand for the 3-month period ending 2023-03-31, per its 10-Q filed 2023-05-22.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:NotesIssued1 · last filed 2023-05-22
- Oncotelic Therapeutics, Inc. notes issued for the quarter ending 2023-03-31 was $71.75K, a 90.05% decline year-over-year.
- Oncotelic Therapeutics, Inc. notes issued for the quarter ending 2022-06-30 was -$71.06K.
- Oncotelic Therapeutics, Inc. notes issued for the quarter ending 2022-03-31 was $721.06K, a 242.87% increase year-over-year.
- Oncotelic Therapeutics, Inc. notes issued for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- Oncotelic Therapeutics, Inc. notes issued for fiscal 2022 was $624.75K, a 197.07% increase from fiscal 2021.
- Oncotelic Therapeutics, Inc. notes issued for fiscal 2021 was $210.30K, a 80.41% decline from fiscal 2020.
- Oncotelic Therapeutics, Inc. notes issued for fiscal 2020 was $1.07M.
| Period end | Notes Issued 3 month | Notes Issued 6 month | Notes Issued 9 month | Notes Issued 12 month |
|---|---|---|---|---|
| 2023-03-31 | $71.75K 10-Q · filed 2023-05-22 | |||
| 2022-12-31 | $624.75K 10-K/A · filed 2023-04-20 | |||
| 2022-06-30 | -$71.06K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $650.00K 10-Q · filed 2022-08-22 | $650.00K derived: sum of 3 quarters · filed 2023-05-22 | $650.00K derived: sum of 4 quarters · filed 2023-05-22 |
| 2022-03-31 | $721.06K 10-Q · filed 2023-05-22 | $721.06K derived: sum of 2 quarters · filed 2023-05-22 | $721.06K derived: sum of 3 quarters · filed 2023-05-22 | $721.06K derived: sum of 4 quarters · filed 2023-05-22 |
| 2021-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-04-20 | $0.00 derived: sum of 2 quarters · filed 2023-04-20 | $0.00 derived: sum of 3 quarters · filed 2023-04-20 | $210.30K 10-K/A · filed 2023-04-20 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $0.00 derived: sum of 2 quarters · filed 2022-08-22 | $210.30K 10-Q · filed 2021-11-22 | $383.30K derived: sum of 4 quarters · filed 2022-08-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $210.30K 10-Q · filed 2022-08-22 | $383.30K derived: sum of 3 quarters · filed 2022-08-22 | $459.36K derived: sum of 4 quarters · filed 2022-08-22 |
| 2021-03-31 | $210.30K 10-Q · filed 2021-05-24 | $383.30K derived: sum of 2 quarters · filed 2022-04-15 | $459.36K derived: sum of 3 quarters · filed 2022-04-15 | $562.80K derived: sum of 4 quarters · filed 2022-04-15 |
| 2020-12-31 | $173.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-15 | $249.06K derived: sum of 2 quarters · filed 2022-04-15 | $352.50K derived: sum of 3 quarters · filed 2022-04-15 | $1.07M 10-K · filed 2022-04-15 |
| 2020-09-30 | $76.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-22 | $179.50K derived: sum of 2 quarters · filed 2021-11-22 | $900.57K 10-Q · filed 2021-11-22 | |
| 2020-06-30 | $103.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-20 | $824.50K 10-Q · filed 2021-08-20 | ||
| 2020-03-31 | $721.06K 10-Q · filed 2021-05-24 |